reaffirm palpabl upsid announc
view sector perform-r report solid beat
re-affirmed guidanc signal plenti upsid potenti
fx tax dec/jan demand activ dental remain chronic
caviti otherwis pristin oper result attribut stock
bp under-perform vs peer on-going dental
disappoint perhap unexpect cfo transit albeit well-
repeat boost full-year guidanc januari
report upsid result consist
posit pre-announce featur robust organ growth
howev primari quibbl oper result continu
dental segment decay due channel inventori
destock spur shift manufacturer-distributor relationship
term guidanc re-affirmed cash ep
rang acknowledg may upsid fx due
appreci eur/usd lower tax rate compani pars
new opportun us tax reform momentum
strong demand dec/jan howev manag stick usual
playbook explicitli updat guidanc earli year
final bombshel announc highly-regard cfo
coma would hand cfo posit veteran financ
leader matt mcgrew januari view one-year notic
hallmark well-sign orderli transit plan
rais cash ep high-end guidanc
due increas fx tailwind price target
biggest surpris dental disappoint year challeng
channel inventori destock dental regress
organ declin headwind expect persist
driven weak equip tradit consum
alreadi two year sinc began treat dental new
acquisit turnaround still appear protract
implications/read-across healthi market plenti seller
heel us tax reform fulli reload balanc
sheet readi resum larger deal size note
plenti optim among seller market thank
favor valuat passag us tax reform expect new
tax regim narrow bid-ask spread reduc tax leakag
seller would incur carve-out
valuat near high-end rel rang trade
premium peer adjust ep cash ep vs target rang
price target assum trade premium
valu usd unless otherwis note
price prior trade day market close estimate unless otherwis note
bloomberg capit market estim upside/downside/target
follow spin fortiv corp believ
re-rat higher beyond rel price-to-earnings rang within
trade histor target rang
given divest cyclic
legaci industri busi believ trade
near high-end rang due strong
outlook potenti catalyst
premium target group multipl price-to-earnings
adjust ep cash ep impli
valuat support sector perform rate
deliv upsid pall cepheid synergies/
accret market enter risk-off environ
believ stock may abl re-rat beyond
high-end rel rang premium
target group multipl adjust ep
also see potenti upsid adjust ep
level includ acceler organ growth end market
carri execut risk misstep
 integr could weigh stock addit
high-qual defens name would also lag
market enter prolong risk-on environ favor
cyclic higher-beta stock could see price-to-earnings contract
premium peer low-end
target rel rang also chanc end market
slowdown result adjust ep closer
valuat
break-up long advoc
break-up scenario unlock long-term sharehold valu
remov vex law larg number hamper
 growth engin view spin-out
industri busi publicly-trad corp
allow remainco revit growth-by-
acquisit engin carri less-cycl best-in-class
portfolio stronger cash gener
rank among higher qualiti earn compani
higher qualiti prime coverag accord
invest framework fundament remain
impress sector-best consecut year
know-how rever danah busi system
posit includ recur revenu market
leadership across portfolio
acquisit long-covet pall corp ideal strateg
fit valuat look pricey last remain public
filtrat pure-play pall like danah wish-list
mani year lead mileston billion
acquisit close pricey
ebitda takeout multipl below-benchmark forecast
spawn new concern among investor danah
compromis disciplin longer term
believ pall huge strateg winner million
target cost synergi priced-for-perfect
valuat add risk integr misstep synergi
shortfal vindic skeptic
balanc sheet fulli reload comfort return
larger deal size keep pipelin
contain million small bolt-on deal
recent disclos becom
comfort return larger multi-billion dollar
deal size vein billion cepheid
acquisit estim roughli billion firepow
compani could feasibl deploy next
month suggest healthi level balanc sheet capacity/
option deal-mak medium term
given expens price-tag below-benchmark
expect return major integr stumbl pall
cepheid would damag faith investor danah
takeaway result
revenu high growth
market high-
single-digit led china
india us
western europ
despit potenti
earn upsid
fx tax reform strong
momentum januari
stick
histor playbook
make major full-year
guidanc chang earli
year
healthi ep beat vs consensu consist posit pre-announce
report cash ep penni recently-rais estim
arguably-stal consensu recal compani posit
pre-announce cash ep would exceed previous commun
guidanc rang see note consensu appear fulli
adjust posit updat also note headlin cash ep figur exclud
impact billion transit tax danah unremit foreign earn
billion gain revalu net defer tax liabil new lower us
corpor tax rate consist posit pre-announce organ revenu growth
quarter ahead compani prior forecast touch
estim strength led life scienc diagnost
environment appli solut howev challeng dental segment
continu decay regress organ declin quarter total compani
oper margin expand bp y/i outpac estim bp
increment margin decent overal oper line came ahead
estim shave half penni higher interest share-count final
free cash flow million quarter impli underwhelm convers
ratio net incom full-year convers still impress
mark compani consecut year convers
exhibit danah earn guidanc vs estim
reaffirm full-year guidanc rang signal potenti earn upsid
fx tax demand momentum unsurprisingli reiter cash ep
guidanc issu less two month ago
outlook meet unlik mani multi-industri compani previous
note us tax reform would produc meaning tailwind compani given
alreadi manag healthi low tax rate howev manag
highlight still preliminari forecast intern examin
opportun lower tax rate even new tax regim also
state transit tax unremit foreign earn would minim
impact free cash flow tune million per year less
current annual cash flow separ current guidanc assum fx
tailwind million revenu ep full-year note
base stale eur/usd rate given euro appreci anoth
sinc decemb like potenti fx tailwind almost doubl vs initi
assumpt manag re-affirmed organ revenu growth guidanc
highlight encourag strength order momentum januari
despit pocket increment tailwind manag steadfastli maintain
still earli year updat guidanc believ
implicit bia upsid beyond current rang final issu
initi cash ep guidanc rang in-lin estim
consensu high-end organ revenu growth
rais cash ep estim high-end
re-affirmed guidanc rang updat fx tailwind assumpt reflect current
exchang rate assum full-year tax rate midpoint
initi guidanc rang though mind potenti
cut tax rate futur organ revenu growth forecast
full-year high-end guidanc rang final
reaffirm cash ep estim high-end guidanc
announc orderli one-year cfo transit plan conjunct earn result
announc current cfo coma begin gradual transit toward
retir pass cfo torch matt mcgrew current group cfo
diagnost dental effect januari big fan mr coma age
capabl held cfo posit almost year sinc april buy-sid
sell-sid poll mr coma perenni top-rank public compani cfo
multi-industri sector help drive four-fold increas market cap
tenur highlight mr comass plan departur age
roughli consist predecessor pat allend left age view
one-year earli notic hallmark well-sign orderli transit plan also
note mr coma continu key role like final
known mr mcgrew age mani year previous vice-president investor
relat serv busi line financ leader work
across intern audit investor relat group cfo sinc
complet confid matt mcgrew compani next cfo
life scienc revenu life scienc organ revenu mark
segment strongest quarterli growth perform four year said growth
includ as-expect bp tailwind recoup demand follow recent
hurrican caus two-week shutdown pall beckman facil puerto rico
florida oper margin expand bp y/i thank db execut
new product innov top-line volum leverag beckman life scienc deliv
high-single-digit organ growth second consecut quarter includ
potenti market share gain accord manag meanwhil pall organ revenu
nearli repres businesss strongest quarterli growth sinc
acquir though includ tailwind hurricane-rel demand
final phenomenex high-single-digit sciex mid-single-digit two
busi began leverag other go-to-market capabl
diagnost organ revenu core oper margin expand
bp y/i beckman coulter low-single-digit radiomet mid-single-digit
leica biosystem high-single-digit importantli cepheid busi saw core
revenu increas driven growth major product line geographi
partli reflect increas demand due sever flu season us
winter full-year cepheid organ revenu almost doubl
manag initi expect announc acquisit late
out-performance driven combin strong commerci execut test
menu expans increas instal base instrument sinc cepheid
acquir expand gross margin bp oper margin
break-even mid-teen today manag confid busi
expand lead market posit gain market share molecular diagnost
dental revenu mix
equip
dental organ revenu regress downtick growth
declin growth specialti consum implant
orthodont off-set declin tradit consum equip sale
busi continu suffer inventori destock distribut channel
roil industri year specif manag discuss
exclus arrang dental market manufactur like
distributor like patterson phase
market open relationship redrawn creat level play field
result market midst rightsiz inventori level new
channel partner work familiar new product catalogu
incent system dynam top-line headwind dental expect persist
least remind manag treat dental new
acquisit past two year turnaround segment includ initi
reposit platform brand consolid gener cost save facil
ration spur higher organ growth new product invest far dental
success consolid number opco ten four past two year
streamlin back-office/manufactur footprint manag believ
dental still middl inning turnaround line-of-sight expand
segment margin mid-teen long-term
environment appli solut segment achiev organ growth
quarter compris mid-single-digit product id water qualiti oper
margin contract bp y/i manag attribut addit product
growth invest water qualiti within product id videojet esko
mid-single-digit x-rite low-single-digit meanwhil water qualiti saw
hach busi acceler mid-single-digit organ growth driven solid perform
across core municip industri end market strength western europ
china chemtreat organ revenu low-single-digit trojan deliv double-
digit growth thank healthi demand bid activ north american municip
market manag confid trojan gain share address market
upcom catalyst point monitor
balanc sheet fulli reload complet bolt-on deal million
keep pipelin contain million small bolt-on deal
recent disclos becom comfort return larger
multi-billion dollar deal-siz vein billion cepheid acquisit net
debt/ebitda year-end estim roughli billion
firepow compani feasibl deploy next month suggest
healthi level balanc sheet capacity/option meaning deal-mak
medium-term importantli manag note seller feel good asset
valuat recent passag us tax reform elimin uncertainti
linger market primari criteria double-digit
year-thre small bolt-on deal year-fiv larger acquisit key
characterist attract target includ fragment market
secular growth driver high barrier entri compani strong brand
direct busi custom intimaci recur revenu
acquisit cepheid expand presenc fastgrow molecular diagnost nov-
complet billion acquisit molecular diagnost player cepheid
deal multipl term ebitda meaning cepheid oper
near break-even although ebitda expect ramp quickli million
million said manag expect deal reach high-single-
digit fall short histor double-digit return benchmark outlook
also includ million cost synergi million sale synergi five
year help drive oper margin expans
pall acquisit expect gener long-term run-rat ep accret
close mileston billion pall acquisit full
execut mode stick tried-and-tru db playbook smooth integr
process manag target cost synergi million million
achiev anoth million target addit pall ahead
schedul margin target due earli success db implement
expect drive ramp earn accret long-term run-rat
current roi pall acquisit estim mid- high-single-digit
driven mid-single-digit core revenu growth bp gross margin
expans bp oper margin expans bp improv on-tim
deliveri million reduct work capit
rel price-to-earnings trade near high-end target rang follow
fortiv spin juli believ achiev multipl expans beyond
histor valuat level given cyclic legaci industri busi
remov portfolio believ target rel premium rang vs
peer applic new portfolio current trade
premium group report ep cash ep believ stock
trade premium target group multipl impli price
target support sector perform rate current level
ev/ebitda premium higher qualiti ev/ebitda basi trade
estim repres rel premium multi-industri peer
group averag surpris premium group given outsiz
 a-driven amort premium price-to-earnings
share price trade premium weight averag price-to-earnings
publicly-trad peer report ep cash ep believ danah
deserv premium reflect market leadership differenti db toolkit
price assum after-tax cost capit beta annual sale growth
termin growth rate
compani report capit market estim
millionsmarjunsepdecmarjunsepdecmarjunsepdecmarjunsepdecseg revenueslif environment appli total revenu organ revenu sale gener incomelif appli expens oper interest expens incom intang per share per share per share earn per share outstand outstand analysi gross oper pre-tax net incom sale sell gener research tax new pension account corpor expens exhibit danah annual incom statement
compani report capit market estim
revenueslif appli revenu sale gener incomelif appli expens oper income/expense- net interest intang per share earn per share per share earn per share outstand outstand analysi gross oper pre-tax net incom sale sell gener research tax asdiscontinu oper electr equip multi-industri
follow spin fortiv corp believ re-rat higher beyond
rel price-to-earnings rang within trade histor target
rang given divest cyclic legaci industri
busi believ trade near high-end rang due healthi
outlook potenti catalyst premium
target group multipl price-to-earnings adjust ep cash ep impli
valuat support sector perform rate
risk rate price target
acquisit one acquisit compani multi-industri sector
alway risk overpay experienc integr difficulti major
deal given pricey pall cepheid acquisit multipl believ integr
stumbl would damag investor trust leadership
organ growth acquisition-focus busi model investor often hone
organ revenu growth metric perceiv miss often
disproportion effect stock earn
econom condit macro trend inflat currenc credit avail suppli
chain materi cost could caus result lower forecast
financi risk disrupt global credit market could caus sale
earn estim optimist
margin sinc gener among highest gross margin sector
degre execut risk would see shortfal profit
regulatori chang govern regul us intern could
neg impact compani especi elev
beneficiari increas regul water product mark
manag success oper histori execut legendari
db framework seen manag talent period poach
industri compani time exodu talent could affect oper
manufactur market profession medic industri commerci
product servic facil locat across countri compani oper
four segment life scienc diagnost dental environment appli solut
also oper differenti framework growth lean leadership tool
process known danah busi system across aspect oper includ
product develop qualiti control global sourc sale market danah
modestli headquart washington employ peopl global
